Lilly

7 results

The offices at Park Place will occupy a pivotal site at the entrance to Eastgate Retail & Business Park

Developer Michael O’Flynn has secured planning permission for further office accommodation on the last remaining commercial site at Park Place in Cork(...)

Carrick Therapeutics founder Elaine Sullivan: “The best piece of advice I received was not to be afraid of trying things.”

It was Dr Elaine Sullivan’s father who prompted her to start up in business after he was diagnosed as having an aggressive stomach cancer and was told(...)

Junior infant Joe Fahy from Dundrum on his first day at school at  St Olaf’s NS, Balally Drive, Dundrum, Dublin 16.  Photograph:  Nick Bradshaw

A soggy August morning gave way to bright sunshine as a new group of infants began their first day of school in Balally, south Dublin, on Wednesday. (...)

Baricitinib had been expected to generate more than $2bn in peak annual sales by taking a share of the lucrative rheumatoid arthritis market.  Photograph: PA Wire

Investors wiped a combined $6 billion (€5.6bn) from the market value of Eli Lilly and its biotech partner Incyte after the US medicines regulator reje(...)

The falure of its Alzheimer medicine - known as Solanezumab, or Sola -  wiped $10 billion off Lilly’s market capitalisation in a single day.

The suspense inside the offices of Eli Lilly this autumn was all but unbearable. After working on a drug to fight Alzheimer’s disease for 15 years, em(...)

Richard Lally with Dr Rosemary O’Hara at Carlow IT’s enviroCORE (Centre of Research and Enterprise in BioEnvironmental Technologies) research centre

Dublin Institute of Technology Top five courses: 1. MSc in Marketing 2. MSc in Strategic Management 3. MSc in Pharmaceutical Quality Assurance &(...)

Immunocore, which was spun out of Oxford University in 2008, is developing novel T cell receptor (TCR) based therapies with the potential to treat a variety of cancers, viral infections and autoimmune diseases

Malin, the Irish-based company set up by a number of former Elan executives to invest in privately held life science assets, has invested $80 million (...)